| |
| Issue |
Title |
| |
| Vol 15, No 2 (2025) |
Planning a clinical trial programme for medicinal products for chronic constipation: An analysis of the European Medicines Agency Guideline |
Abstract
PDF (Rus)
|
|
I. A. Proskurina, T. E. Gorskaya, R. S. Ilin, D. V. Goryachev |
| |
| Vol 15, No 1 (2025) |
Basic Principles for Calculating the Required Number of Participants in Clinical Trials. Part 2. Survival Analysis (Review) |
Abstract
PDF (Rus)
|
|
O. V. Shreder, D. V. Goryachev, V. A. Merkulov |
| |
| Vol 15, No 1 (2025) |
Planning a Clinical Development Programme for Radiopharmaceuticals: An Analysis of International Guidelines and Expertise |
Abstract
PDF (Rus)
|
|
D. V. Goryachev, I. V. Lysikova, A. A. Chernaia, D. D. Kushnir |
| |
| Vol 15, No 1 (2025) |
Planning a Clinical Development Programme for Medicinal Products for Functional Gastrointestinal Disorders |
Abstract
PDF (Rus)
|
|
I. P. Avakiants, E. A. Gerasimets, E. S. Petrova, D. V. Goryachev |
| |
| Vol 14, No 5 (2024) |
Experience in the Examination of Bioequivalence Clinical Trials of Locally Applied and Locally Acting Medicinal Products in Accordance with the Eurasian Economic Union Procedures |
Abstract
PDF (Rus)
|
|
O. Yu. Ivanova, O. L. Shikhovtsova |
| |
| Vol 14, No 5 (2024) |
Organisation of the Work of Bioanalytical Laboratories according to the Principles of Good Clinical Laboratory Practice (Review) |
Abstract
PDF (Rus)
|
|
I. S. Giba |
| |
| Vol 14, No 4 (2024) |
Planning a Clinical Development Programme for Medicinal Products for Irritable Bowel Syndrome: An Analysis of the European Medicines Agency’s Recommendations |
Abstract
PDF (Rus)
|
|
E. A. Gerasimets, N. A. Rumyantsev, R. S. Ilin, D. V. Goryachev |
| |
| Vol 14, No 3 (2024) |
Basic Principles for Calculating the Required Number of Participants in Clinical Trials. Part 1. Common Approaches (Review) |
Abstract
PDF (Rus)
|
|
O. V. Shreder, D. V. Goryachev, V. A. Merkulov |
| |
| Vol 14, No 3 (2024) |
Programme for Studying Medicinal Products for Generalised Anxiety Disorder: Analysis of the European Medicines Agency Guideline |
Abstract
PDF (Rus)
|
|
A. P. Solovyova, I. M. Surmilo |
| |
| Vol 12, No 4 (2022) |
Radioactivity distribution in the blood and urine of patients receiving systemic therapy with a 177Lu radiopharmaceutical and local (intra-articular) therapy with a 188Re radiopharmaceutical |
Abstract
PDF (Rus)
|
|
E. D. Stepchenkova, V. K. Tishchenko, O. P. Vlasova, V. M. Petriev, N. S. Legkodimova, V. V. Krylov, A. V. Fedorova, E. A. Kuzenkova, A. A. Ostroukhoff, P. V. Shegai |
| |
| 1 - 10 of 10 Items |
|
